首頁 > 市場調查報告書 > 醫療設備

體外診斷癌症

市場調查報告書

商品編碼

1788278

全球肺癌篩檢軟體市場

Lung Cancer Screening Software

出版日期: 2025年08月12日 | 出版商:

Global Industry Analysts, Inc. | 英文 98 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球肺癌篩檢軟體市場規模將達 4,050 萬美元

2024 年全球肺癌篩檢軟體市場規模估計為 2,840 萬美元，預計到 2030 年將達到 4,050 萬美元，在 2024-2030 年分析期內的複合年成長率為 6.1%。

美國市場規模估計為 750 萬美元，中國市場預計複合年成長率為 6.0%

美國肺癌篩檢軟體市場規模預計在2024年達到750萬美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到650萬美元，在2024-2030年的分析期間內，複合年成長率為6.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為5.7%和5.2%。在歐洲，預計德國市場的複合年成長率為4.9%。

全球肺癌篩檢軟體市場－徹底改變早期檢測與診斷

是什麼讓肺癌篩檢軟體如此受歡迎？

肺癌是全球癌症相關死亡的主要原因之一，發現較晚會導致高死亡率。早期診斷可顯著提高存活率，而肺癌篩檢軟體成為提高檢測準確性和效率的關鍵工具。人工智慧 (AI) 和機器學習 (ML) 在醫學影像領域的應用正在推動市場發展，因為它可以幫助放射科醫生和腫瘤科醫生更準確地識別肺結節。政府針對長期吸菸者等高風險族群的措施和篩檢計畫進一步推動了對先進篩檢解決方案的需求。肺癌篩檢軟體正擴大被整合到醫院放射科和遠端醫療平台中，使早期檢測更加便捷有效。

創新如何推動肺癌篩檢軟體的效能？

人工智慧演算法與深度學習模型的整合顯著提高了肺癌篩檢軟體的準確性。這些技術能夠檢測出微小結節，從而增強影像分析能力，減少診斷中的假陽性和假陰性。雲端基礎的篩檢平台和遠端醫療整合正在擴大篩檢服務的覆蓋範圍，尤其是在偏遠和服務不足的地區。預測分析的應用正在幫助醫生評估患者風險因素，並優先考慮高風險病例進行進一步評估。此外，將肺癌篩檢軟體與電子健康記錄(EHR) 結合，可簡化工作流程，提高效率，實現即時數據分析和自動報告。

市場促進因素有哪些？

推動肺癌篩檢軟體市場成長的因素有很多。肺癌盛行率的上升和對早期檢測的日益重視是關鍵促進因素。政府法規和醫療政策對肺癌篩檢計畫的支持，尤其是在已開發國家，正在加速其普及率。人工智慧和自動化在醫療保健領域的應用日益廣泛，以及對數位醫療技術的投資不斷增加，進一步推動了對複雜篩檢解決方案的需求。此外，雲端基礎醫學影像處理平台的擴展以及軟體開發人員和醫療保健提供者之間日益加強的合作，也促進了市場的發展。

面臨哪些挑戰和未來機會？

儘管肺癌篩檢軟體市場潛力巨大，但它仍面臨著許多挑戰，例如高昂的實施成本、資料隱私問題以及與現有醫療IT系統的互通性問題。依賴手動影像分析的傳統放射科醫生的抵制也可能減緩其應用。然而，人工智慧輔助診斷的日益普及、更具成本效益的雲端基礎解決方案的開發以及法規合規性的進步，正在創造巨大的機會。未來市場的成長將由人工智慧支援的即時診斷、基於基因和生活方式因素的個人化篩檢通訊協定以及肺癌篩檢軟體與行動醫療應用的整合所驅動。

部分

單段

受訪公司範例

C the Signs
Canon Medical Systems Corporation
Dxcover Ltd
Eon
FUJIFILM Holdings Corporation
Guardant Health
iDNA
ITK-SNAP
Koninklijke Philips NV
MagView
Medtronic
MRS Systems, Inc.
Nuance Communications, Inc.
Oatmeal Health
Optellum
PenRad Technologies, Inc.
Siemens Healthineers AG
Thynk Health
Volpara Health
VoxelCloud

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 沒有查詢通用的 LLM 或特定產業的SLM，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The Lung Cancer Screening Software market in the U.S. is estimated at US$7.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Million by the year 2030 trailing a CAGR of 6.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Lung Cancer Screening Software Market - Revolutionizing Early Detection and Diagnosis

Why Is Lung Cancer Screening Software Gaining Popularity?

Lung cancer is one of the leading causes of cancer-related deaths worldwide, with a high mortality rate due to late-stage detection. Early diagnosis significantly improves survival rates, and lung cancer screening software is emerging as a crucial tool in enhancing detection accuracy and efficiency. The adoption of artificial intelligence (AI) and machine learning (ML) in medical imaging is driving the market, as these technologies help radiologists and oncologists identify lung nodules with greater precision. Government initiatives and screening programs aimed at high-risk populations, such as long-term smokers, are further propelling the demand for advanced screening solutions. The increasing integration of lung cancer screening software into hospital radiology departments and telemedicine platforms is making early detection more accessible and effective.

How Are Innovations Enhancing the Performance of Lung Cancer Screening Software?

The integration of AI-driven algorithms and deep learning models is significantly improving the accuracy of lung cancer screening software. These technologies enhance image analysis by detecting even the smallest nodules, reducing false positives and false negatives in diagnosis. Cloud-based screening platforms and telemedicine integration are expanding access to screening services, particularly in remote and underserved areas. The adoption of predictive analytics is helping physicians assess patient risk factors and prioritize high-risk cases for further evaluation. Additionally, the combination of lung cancer screening software with electronic health records (EHRs) is streamlining workflow efficiency, allowing for real-time data analysis and automated reporting.

What Are the Key Market Drivers?

Several factors are fueling the growth of the lung cancer screening software market. The rising prevalence of lung cancer and the increasing emphasis on early detection are key drivers. Government regulations and healthcare policies supporting lung cancer screening programs, particularly in developed nations, are accelerating adoption rates. The growing use of AI and automation in healthcare, along with increasing investments in digital health technologies, is further boosting the demand for sophisticated screening solutions. Additionally, the expansion of cloud-based medical imaging platforms and the increasing collaboration between software developers and healthcare providers are contributing to market growth.

What Challenges and Future Opportunities Exist?

Despite its potential, the lung cancer screening software market faces challenges such as high implementation costs, data privacy concerns, and interoperability issues with existing healthcare IT systems. Resistance from traditional radiologists who rely on manual image analysis may also slow down adoption. However, the growing acceptance of AI-assisted diagnostics, the development of more cost-effective cloud-based solutions, and advancements in regulatory compliance are creating significant opportunities. Future growth in the market will be driven by AI-powered real-time diagnosis, personalized screening protocols based on genetic and lifestyle factors, and the integration of lung cancer screening software into mobile health applications.

SCOPE OF STUDY:

The report analyzes the Lung Cancer Screening Software market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Single Segment

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

C the Signs
Canon Medical Systems Corporation
Dxcover Ltd
Eon
FUJIFILM Holdings Corporation
Guardant Health
iDNA
ITK-SNAP
Koninklijke Philips N.V.
MagView
Medtronic
MRS Systems, Inc.
Nuance Communications, Inc.
Oatmeal Health
Optellum
PenRad Technologies, Inc.
Siemens Healthineers AG
Thynk Health
Volpara Health
VoxelCloud

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Lung Cancer Screening Software - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Global Lung Cancer Incidence Rates Throws the Spotlight on Early Detection and Screening Solutions
- Growing Emphasis on Precision Medicine Propels Demand for AI-Driven Lung Cancer Screening Software
- Increasing Government-Led Screening Programs Expands Addressable Market Opportunity for Lung Cancer Detection Tools
- Escalating Awareness Campaigns on Smoking Risks Drives Adoption of Preventive Screening Technologies
- Advancements in AI and Deep Learning Algorithms Strengthen the Business Case for Automated Lung Nodule Detection
- Integration of Lung Cancer Screening Software into Radiology Workflows Accelerates Demand Among Hospitals and Imaging Centers
- Cloud-Based Diagnostic Platforms Sustain Growth in Remote Screening and Teleradiology Markets
- Reimbursement Reforms and Coverage Expansion in Developed Markets Drive Commercial Adoption
- Surge in Geriatric Population at High Risk of Lung Cancer Spurs Demand for Preventive Screening Tools
- Rapid Uptake of Low-Dose CT (LDCT) in Routine Clinical Practice Fuels Growth of Compatible Screening Software
- Expansion of National Screening Guidelines Across Key Markets Boosts Software Deployment
- Enhanced Image Processing Capabilities and 3D Visualization Drives Market Penetration in Oncology Imaging
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Lung Cancer Screening Software Market Analysis of Annual Sales in US$ for Years 2015 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Lung Cancer Screening Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
- TABLE 4: World 15-Year Perspective for Lung Cancer Screening Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 5: USA Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 6: USA Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
CANADA
- TABLE 7: Canada Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 8: Canada Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
JAPAN
- Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 9: Japan Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 10: Japan Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
CHINA
- Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 11: China Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 12: China Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
EUROPE
- Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 13: Europe Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
- TABLE 14: Europe Historic Review for Lung Cancer Screening Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
- TABLE 15: Europe 15-Year Perspective for Lung Cancer Screening Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
FRANCE
- Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 16: France Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 17: France Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
GERMANY
- Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 18: Germany Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 19: Germany Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
ITALY
- TABLE 20: Italy Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 21: Italy Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
UNITED KINGDOM
- Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 22: UK Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 23: UK Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
REST OF EUROPE
- TABLE 24: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 25: Rest of Europe Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
ASIA-PACIFIC
- Lung Cancer Screening Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 26: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 27: Asia-Pacific Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
REST OF WORLD
- TABLE 28: Rest of World Recent Past, Current & Future Analysis for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
- TABLE 29: Rest of World Historic Review for Lung Cancer Screening Software by Segment - Lung Cancer Screening Software Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR